In vivo expression of mutant calpains in the eye using lentivirus

Katherine J. Wert, Vinit B. Mahajan

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Exome sequencing has identified many candidate genes and mutations for human diseases, but the functional validation of these candidates is a time-consuming and costly process. Here, we describe a method which uses lentiviruses to overexpress calpain mutations that may play a role in dominant diseases such as autosomal dominant neovascular inflammatory vitreoretinopathy (ADNIV). The use of lentivirus to deliver the mutant calpain allows for a cost-effective, rapid, and efficient approach to test whether or not a candidate gene mutation from exome sequencing acts as the disease-causing allele for a human disorder. This method also provides for a comparison of different candidate mutations from a single gene identified by exome sequencing, as well as elucidating the mechanisms underlying these complex human disorders. Furthermore, this chapter focuses on two different methods to deliver mutant calpain to the cells of the eye, using either a subretinal or an intravitreal injection of the lentivirus into the mouse eye.

Original languageEnglish (US)
Title of host publicationMethods in Molecular Biology
PublisherHumana Press Inc.
Pages233-247
Number of pages15
DOIs
StatePublished - Jan 1 2019
Externally publishedYes

Publication series

NameMethods in Molecular Biology
Volume1915
ISSN (Print)1064-3745

Fingerprint

Lentivirus
Calpain
Exome
Mutation
Genes
Proliferative Vitreoretinopathy
Intravitreal Injections
Alleles
Costs and Cost Analysis

Keywords

  • Calpain
  • CAPN5
  • Intravitreal injection
  • Lentiviral vectors
  • Molecular cloning
  • Mouse eye
  • Subretinal injection

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

Wert, K. J., & Mahajan, V. B. (2019). In vivo expression of mutant calpains in the eye using lentivirus. In Methods in Molecular Biology (pp. 233-247). (Methods in Molecular Biology; Vol. 1915). Humana Press Inc.. https://doi.org/10.1007/978-1-4939-8988-1_18

In vivo expression of mutant calpains in the eye using lentivirus. / Wert, Katherine J.; Mahajan, Vinit B.

Methods in Molecular Biology. Humana Press Inc., 2019. p. 233-247 (Methods in Molecular Biology; Vol. 1915).

Research output: Chapter in Book/Report/Conference proceedingChapter

Wert, KJ & Mahajan, VB 2019, In vivo expression of mutant calpains in the eye using lentivirus. in Methods in Molecular Biology. Methods in Molecular Biology, vol. 1915, Humana Press Inc., pp. 233-247. https://doi.org/10.1007/978-1-4939-8988-1_18
Wert KJ, Mahajan VB. In vivo expression of mutant calpains in the eye using lentivirus. In Methods in Molecular Biology. Humana Press Inc. 2019. p. 233-247. (Methods in Molecular Biology). https://doi.org/10.1007/978-1-4939-8988-1_18
Wert, Katherine J. ; Mahajan, Vinit B. / In vivo expression of mutant calpains in the eye using lentivirus. Methods in Molecular Biology. Humana Press Inc., 2019. pp. 233-247 (Methods in Molecular Biology).
@inbook{4b08d66edb9944f4835a556543102691,
title = "In vivo expression of mutant calpains in the eye using lentivirus",
abstract = "Exome sequencing has identified many candidate genes and mutations for human diseases, but the functional validation of these candidates is a time-consuming and costly process. Here, we describe a method which uses lentiviruses to overexpress calpain mutations that may play a role in dominant diseases such as autosomal dominant neovascular inflammatory vitreoretinopathy (ADNIV). The use of lentivirus to deliver the mutant calpain allows for a cost-effective, rapid, and efficient approach to test whether or not a candidate gene mutation from exome sequencing acts as the disease-causing allele for a human disorder. This method also provides for a comparison of different candidate mutations from a single gene identified by exome sequencing, as well as elucidating the mechanisms underlying these complex human disorders. Furthermore, this chapter focuses on two different methods to deliver mutant calpain to the cells of the eye, using either a subretinal or an intravitreal injection of the lentivirus into the mouse eye.",
keywords = "Calpain, CAPN5, Intravitreal injection, Lentiviral vectors, Molecular cloning, Mouse eye, Subretinal injection",
author = "Wert, {Katherine J.} and Mahajan, {Vinit B.}",
year = "2019",
month = "1",
day = "1",
doi = "10.1007/978-1-4939-8988-1_18",
language = "English (US)",
series = "Methods in Molecular Biology",
publisher = "Humana Press Inc.",
pages = "233--247",
booktitle = "Methods in Molecular Biology",

}

TY - CHAP

T1 - In vivo expression of mutant calpains in the eye using lentivirus

AU - Wert, Katherine J.

AU - Mahajan, Vinit B.

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Exome sequencing has identified many candidate genes and mutations for human diseases, but the functional validation of these candidates is a time-consuming and costly process. Here, we describe a method which uses lentiviruses to overexpress calpain mutations that may play a role in dominant diseases such as autosomal dominant neovascular inflammatory vitreoretinopathy (ADNIV). The use of lentivirus to deliver the mutant calpain allows for a cost-effective, rapid, and efficient approach to test whether or not a candidate gene mutation from exome sequencing acts as the disease-causing allele for a human disorder. This method also provides for a comparison of different candidate mutations from a single gene identified by exome sequencing, as well as elucidating the mechanisms underlying these complex human disorders. Furthermore, this chapter focuses on two different methods to deliver mutant calpain to the cells of the eye, using either a subretinal or an intravitreal injection of the lentivirus into the mouse eye.

AB - Exome sequencing has identified many candidate genes and mutations for human diseases, but the functional validation of these candidates is a time-consuming and costly process. Here, we describe a method which uses lentiviruses to overexpress calpain mutations that may play a role in dominant diseases such as autosomal dominant neovascular inflammatory vitreoretinopathy (ADNIV). The use of lentivirus to deliver the mutant calpain allows for a cost-effective, rapid, and efficient approach to test whether or not a candidate gene mutation from exome sequencing acts as the disease-causing allele for a human disorder. This method also provides for a comparison of different candidate mutations from a single gene identified by exome sequencing, as well as elucidating the mechanisms underlying these complex human disorders. Furthermore, this chapter focuses on two different methods to deliver mutant calpain to the cells of the eye, using either a subretinal or an intravitreal injection of the lentivirus into the mouse eye.

KW - Calpain

KW - CAPN5

KW - Intravitreal injection

KW - Lentiviral vectors

KW - Molecular cloning

KW - Mouse eye

KW - Subretinal injection

UR - http://www.scopus.com/inward/record.url?scp=85059928704&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059928704&partnerID=8YFLogxK

U2 - 10.1007/978-1-4939-8988-1_18

DO - 10.1007/978-1-4939-8988-1_18

M3 - Chapter

C2 - 30617808

AN - SCOPUS:85059928704

T3 - Methods in Molecular Biology

SP - 233

EP - 247

BT - Methods in Molecular Biology

PB - Humana Press Inc.

ER -